Study of Stool Microbiota in Two Diverse Cohorts of Asian and Its Influence on Allergy Development
NCT ID: NCT00713089
Last Updated: 2014-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
74 participants
OBSERVATIONAL
2006-03-31
2009-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mold Sensitization Associated Severe Asthma Exacerbation
NCT03690349
Dynamics of the Upper and Lower Airway Respiratory Microbiomes Associated With Severe Infant Asthma
NCT06044051
Oral Bacteria and Allergic Disease in Children
NCT00438646
Airway Microbiota Based Treatment of Asthma in Preschool Children
NCT04527016
Environmental Mycobiota: In-depth Characterisation and Determinants Involved in Asthma Emission
NCT05789927
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
75 subjects randomised into the placebo arm of an ongoing randomised double-blind placebo controlled clinical trial at National University Hospital, Singapore
No interventions assigned to this group
2
The expecting mothers visiting at the well mother clinics at Gadjah Mada University Hospital were invited to participate in the study
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Either parent or sibling (ie first degree relative) has a history of atopy. This will be evidenced by a doctor-diagnosis of asthma, allergic rhinitis or eczema AND a positive skin prick test/specific IgE test to any of a panel of common allergens.
* Parents agree to the child's participation in the study and sign the Informed Consent.
* The subject and the parents are willing to comply with procedures and both child and parents are able to keep to scheduled clinic visits.
* Both parents are at contactable range (with valid mobile or land line numbers) for study team to arrange and schedule clinic visits and complete telephone interviews.
Post-delivery evaluation
* The subject is born full term (at least 37 weeks gestation).
* The subject does not have major congenital malformations/major illness as judged by the doctor.
* The subject is in otherwise good, stable health on the basis of medical history, physical examination.
* Family appears to be able to successfully complete this study.
Exclusion Criteria
* The parent is unable/ unwilling to comply with procedures.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gadjah Mada University
OTHER
National University Hospital, Singapore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bee Wah Lee, MD
Role: PRINCIPAL_INVESTIGATOR
National University Hospital, Singapore
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gadjah Mada University Hospital
Yogyakarta, , Indonesia
National University Hospital
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SQNB01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.